MDT
66
-4
RRC
56
4
LRCX
81
7
CMS
60
2
VRTX
60
-4
SPG
46
-2
RHI
47
2
XRAY
46
5
ZBH
62
-3
MNST
62
2
IRM
49
3
SYY
54
4
HRL
15
6
EMN
56
-2
GPC
66
5
CINF
58
-5
BAX
48
4
CLX
56
3
LB
29
11
STX
78
5
MDT
66
-4
RRC
56
4
LRCX
81
7
CMS
60
2
VRTX
60
-4
SPG
46
-2
RHI
47
2
XRAY
46
5
ZBH
62
-3
MNST
62
2
IRM
49
3
SYY
54
4
HRL
15
6
EMN
56
-2
GPC
66
5
CINF
58
-5
BAX
48
4
CLX
56
3
LB
29
11
STX
78
5
Financhill
Back

Institute of BioMedical Research Corp. 10K Form

Buy
52

MRES
Institute of BioMedical Research Corp.

Last Price:
$0.0100
Seasonality Move:
22.47%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive MRES News And Ratings

See the #1 stock for the next 7 days that we like better than MRES

MRES Financial Statistics

Sales & Book Value

Annual Sales: $49.5K
Cash Flow: $0
Price / Cash Flow: 0
Annual Sales: $0.00
Price / Book: 21.74

Profitability

Net Income (TTM): $0
Gross Margin: $21.4K
Return on Equity: 0%
Return on Assets: 0%

Institute of BioMedical Research Corp. Earnings Forecast

Key Institute of BioMedical Research Corp. Financial Ratios

  • The Gross Profit Margin over the past 8 years for MRES is 43.23%.
  • The Selling, General & Administrative Expenses for MRES have been equal to 1,793.94% of Gross Profit Margin.
  • The Research & Development expenses have been -222.42% of Revenue.
  • The Net Earning history of MRES is -1,494.14% of Total Revenues.
  • Per Share Earnings over the last 11 years have been positive in 3 years.

Institute of BioMedical Research Corp. Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: OTCM
Current Symbol: MRES
Website: mrescorp.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 0
Quick Ratio: 0

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

MRES Technical Analysis vs Fundamental Analysis

Buy
52
Institute of BioMedical Research Corp. (MRES) is a Buy

Is Institute of BioMedical Research Corp. a Buy or a Sell?